Clinical Trial Update: Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the effects of Epalrestat in diabetic patients with peripheral neuropathy and central nervous system involvement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• epalrestat (epalrestat)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Diabetes | Phase 4 | Status: UNKNOWN